NOIDS.wiki
Calculator
Shop Potency Calculator
Cannabis Science

HU-210: Specs, Where It Fits & Evidence

Cannabinoid · Synthetic (research chemical)

Yes (very potent)SyntheticClassical cannabinoidResearch tool

HU-210 is a fully synthetic classical cannabinoid, roughly 100 to 800 times as potent as THC and used strictly in research; synthetic cannabinoids are linked to serious harm and deaths.

Full name
HU-210
Molecular formula
C25H38O3
Class / family
Classical cannabinoid
Precursor / from
Synthetic
Intoxicating?
Yes (very potent)
Research status
Research tool

Where it fits

HU-210 derives from Synthetic. See the Synthetic & altered cannabinoids index for how it relates to the rest of the family.

What the research shows

Direct human research on HU-210 is minimal; it is characterised mainly by its chemistry and its place in the cannabinoid family rather than by clinical studies. We flag that plainly rather than overstate it.

Safety

A fully synthetic cannabinoid, covered for education and harm reduction only. Synthetic cannabinoids are potent, unpredictable and linked to serious harm and deaths. No synthesis, dose or source information appears on this site.

Classical dimethylheptyl stereochemistry and full CB1/CB2 agonism

Synthesized at the Hebrew University of Jerusalem in 1988 by Raphael Mechoulam and colleagues, HU-210 ((6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; C25H38O3) replaces the pentyl side chain of delta-8-THC with a branched 1,1-dimethylheptyl chain, yielding a (-)-enantiomer with sub-nanomolar binding affinity at human CB1 (Ki ~ 0.06 nM) and CB2 (Ki ~ 0.52 nM) receptors (Mechoulam et al., 1988, Experientia, PubMed PMID 2547909). Unlike partial phytocannabinoid agonists in the cannabinoids index, HU-210 acts as a high-efficacy full agonist that is roughly 100 to 800 times more potent than delta-9-THC in vivo and is classified among controlled synthetic cannabinoids (Pertwee et al., 2002, Pharmacological Reviews, PubMed PMID 12052038).

FAQ

Is HU-210 intoxicating?

Yes. HU-210 is an extremely potent full agonist at human CB1 receptors (Ki ~ 0.06 nM), exhibiting roughly 100 to 800 times the pharmacological potency of delta-9-THC in preclinical models (PubMed PMID 2547909).

Where does HU-210 come from?

HU-210 does not occur in Cannabis sativa; it was first synthesized in 1988 at the Hebrew University of Jerusalem by Raphael Mechoulam and colleagues as a stereospecific classical cannabinoid probe.

How does HU-210 differ from HU-211 (dexanabinol)?

HU-210 is the levorotatory (-)-(6aR,10aR) enantiomer that potently activates CB1 and CB2 receptors, whereas its mirror-image (+)-(6aS,10aS) enantiomer HU-211 does not bind CB1 receptors and lacks cannabinoid intoxication.

Part of the NOIDS cannabinoids index. Educational reference, not medical advice.

This article is for educational purposes only. Always follow local laws regarding cannabis preparation and use.

Scroll to Top